India’s drug regulatory authority steps up surveillance on generic GLP-1 weight-loss drugs
Increased audits aim to curb misuse of semaglutide-based weight-loss and diabetes treatments
Increased audits aim to curb misuse of semaglutide-based weight-loss and diabetes treatments
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
